Highly Potent & Oncology

Our Highly Potent & Oncology Platform utilizes state-of-the-art high containment technology and processes to manufacture Highly Potent Active Pharmaceutical Ingredients (APIs) and Drug Products. Inthera PharmaMed in partnership with Seatrack International Group manufacturing facilities provides expertise and reliability which is second to none in quality, delivery times and high Right-First-Time performance.

Platform Description

Our platform offers:

>> Advanced Chemical Synthesis

>> Cytotoxic & Cytostatic APIs

>> Oral Dose (tablets & capsules)

>> Injectables (liquid and lyophilized)

>> Highly Potent Peptides

>> Linker-warheads for Drug Conjugates

>> Preparative Chromatography Expertise

Platform Capabilities

Drug Products

Regulatory & Supply Chain

Primary & Secondary Packaging